Deep Sclerectomy With a New Nonabsorbable Uveoscleral Implant (Esnoper-Clip): 1-Year Outcomes
| Autor: | Loscos-Arenas, Jordi, Parera-Arranz, Angels, Romera-Romera, Pau, Castellvi-Manent, Jordi, Sabala-Llopart, Antoni, de la Cámara-Hermoso, Julio, Universitat Autònoma de Barcelona |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Male
medicine.medical_specialty Intraocular pressure genetic structures Eye disease Prosthesis Implantation Glaucoma open-angle glaucoma Lasers Solid-State Original Studies Aqueous Humor Tonometry Ocular Postoperative Complications Deep sclerectomy Ophthalmology medicine Humans Open-angle glaucoma Intraoperative Complications Uvea Sclerostomy Esnoper-Clip Intraocular Pressure Aged business.industry deep sclerectomy Prostheses and Implants medicine.disease eye diseases Surgery Sclera medicine.anatomical_structure Treatment Outcome Optic nerve Methacrylates Female Implant sense organs business Glaucoma Open-Angle |
| Zdroj: | Journal of Glaucoma Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona |
| ISSN: | 1536-481X 1057-0829 |
| Popis: | Glaucoma is a complex eye disease which is the second cause of blindness in the world. It consists of the progressive deterioration of the layer of retinal nerve fibers and of the optic nerve, which lead to the appearance of defects in the visual field and of atrophy of the optic nerve. In the majority of cases, this pathology is associated with increased intraocular pressure (IOP) due to the inhibition of correct drainage of the aqueous humor of the eye. The management of glaucoma requires chronic treatment with a spectrum of therapeutic options including drugs, laser treatment, incisional filtration surgery, drainage devices, and surgical implants. Deep sclerectomy (DS) is a nonpenetrating procedure for the treatment of open-angle glaucoma (OAG). This can be enhanced with intraoperative mitomycin-C (MMC) or with the use of implants designed to avoid secondary collapse by maintaining the space created after removing the deep scleral flap. These devices can be implanted intrasclerally or in the supraciliary space, with a view to facilitating trabecular and uveoscleral outflow. Its implantation in the scleral bed has been more widely practiced, but there are also a few reports of the placement of the implant in the supraciliary space1,2 which indicate that it may be a promising alternative. It is still unknown whether placing an implant in the supraciliary space produces a higher reduction in IOP than in the scleral space, but the maintenance of both spaces seems to be related to satisfactory IOP control. One problem of supraciliary implantation is that the size of the intrascleral lake could be reduced and this could lead to less IOP reduction.1 Esnoper-Clip is a new nonreabsorbable foldable hema implant with 2 ft, one for the intrascleral bed and the other for the supraciliary space. Its shape seeks to increase the trabecular and uveoscleral outflow, maintaining both spaces and achieve higher intrascleral blebs. The aim of this study was to evaluate the safety and effectiveness of this implant after a 12-month follow-up and if it could be an alternative to existing implants. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|